Current status of therapeutic targeting of developmental signalling pathways in oncology.

Tobias Kiesslich; Frieder Berr; Beate Alinger; Ralf Kemmerling; Martin Pichler; Matthias Ocker; Daniel Neureiter

Current status of therapeutic targeting of developmental signalling pathways in oncology.

Tobias Kiesslich (Erstautor/-in)
, Frieder Berr (Co-Autor/-in)
, Beate Alinger
, Ralf Kemmerling
, Martin Pichler
, Matthias Ocker
, Daniel Neureiter^* (Letztautor/-in)

^*Korrespondierende/r Autor/-in für diese Arbeit

Publikation: Beitrag in Fachzeitschrift › Übersichtsarbeit › Begutachtung

27 Quellenangaben (Web of Science)

Originalsprache	Englisch
Seiten (von - bis)	2184-2220
Fachzeitschrift	CURRENT PHARMACEUTICAL BIOTECHNOLOGY
Jahrgang	13
Ausgabenummer	11
Publikationsstatus	Veröffentlicht - 2012

Dieses zitieren

@article{3424234890714f7b879d12f7188c938d,

title = "Current status of therapeutic targeting of developmental signalling pathways in oncology.",

keywords = "GROWTH-FACTOR-BETA, EPITHELIAL-MESENCHYMAL TRANSITION, CANCER STEM-CELLS, HUMAN BREAST-CANCER, ACUTE LYMPHOBLASTIC-LEUKEMIA, E-CADHERIN EXPRESSION, CHRONIC LYMPHOCYTIC-LEUKEMIA, BONE MORPHOGENETIC PROTEINS, SMALL-MOLECULE INHIBITOR, RECEPTOR-TYPE-II",

author = "Tobias Kiesslich and Frieder Berr and Beate Alinger and Ralf Kemmerling and Martin Pichler and Matthias Ocker and Daniel Neureiter",

year = "2012",

language = "English",

volume = "13",

pages = "2184--2220",

journal = "CURRENT PHARMACEUTICAL BIOTECHNOLOGY",

issn = "1389-2010",

number = "11",

}

TY - JOUR

T1 - Current status of therapeutic targeting of developmental signalling pathways in oncology.

AU - Kiesslich, Tobias

AU - Berr, Frieder

AU - Alinger, Beate

AU - Kemmerling, Ralf

AU - Pichler, Martin

AU - Ocker, Matthias

AU - Neureiter, Daniel

PY - 2012

Y1 - 2012

KW - GROWTH-FACTOR-BETA

KW - EPITHELIAL-MESENCHYMAL TRANSITION

KW - CANCER STEM-CELLS

KW - HUMAN BREAST-CANCER

KW - ACUTE LYMPHOBLASTIC-LEUKEMIA

KW - E-CADHERIN EXPRESSION

KW - CHRONIC LYMPHOCYTIC-LEUKEMIA

KW - BONE MORPHOGENETIC PROTEINS

KW - SMALL-MOLECULE INHIBITOR

KW - RECEPTOR-TYPE-II

M3 - Review article

C2 - 21605074

SN - 1389-2010

VL - 13

SP - 2184

EP - 2220

JO - CURRENT PHARMACEUTICAL BIOTECHNOLOGY

JF - CURRENT PHARMACEUTICAL BIOTECHNOLOGY

IS - 11

ER -